Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

Enhancing the effector functions is one of the major strategies for the development of engineered monoclonal antibodies. Here, we will discuss the development of effector function-enhanced antibodies, and the solutions provided by Creative Biolabs.

Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.

Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release, and how to use these findings as optimal therapeutic intervention timepoints for siRNA-based Huntington's disease therapies.

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column.